Good manufacturing practice requirements for the production of tissue vitrification and warming and recovery kits for clinical research.
Ontology highlight
ABSTRACT: Products that are manufactured for use in a clinical trial, with the intent of gaining US Food and Drug Administration (FDA) approval for clinical use, must be produced under an FDA approved investigational new drug (IND) application. We describe work done toward generating reliable methodology and materials for preserving ovarian cortical tissue through a vitrification kit and reviving this tissue through a warming and recovery kit. We have described the critical steps, procedures, and environments for manufacturing products with the intent of submitting an IND. The main objective was to establish an easy-to-use kit that would ensure standardized procedures for quality tissue preservation and recovery across the 117 Oncofertility Consortium sites around the globe. These kits were develope
SUBMITTER: Laronda MM
PROVIDER: S-EPMC5306410 | biostudies-literature | 2017 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA